These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24025401)

  • 41. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular mechanisms of hepatitis C virus (HCV) replication - implications for the development of antiviral drugs].
    Bühler S; Bartenschlager R
    Z Gastroenterol; 2011 Jul; 49(7):836-44. PubMed ID: 21766263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
    Suzuki T
    Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses.
    Roberts CG; Chan-Myers HB; Favero MS
    Am J Infect Control; 2008 Apr; 36(3):223-6. PubMed ID: 18371520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives.
    Salim MT; Aoyama H; Sugita K; Watashi K; Wakita T; Hamasaki T; Okamoto M; Urata Y; Hashimoto Y; Baba M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):714-9. PubMed ID: 22085716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro.
    Sandmann L; Wilson M; Back D; Wedemeyer H; Manns MP; Steinmann E; Pietschmann T; von Hahn T; Ciesek S
    Antiviral Res; 2012 Oct; 96(1):51-8. PubMed ID: 22842003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus.
    Lee WP; Lan KL; Liao SX; Huang YH; Hou MC; Lan KH
    Am J Chin Med; 2018; 46(4):835-852. PubMed ID: 29737209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV.
    Yan R; Zhao Z; He Y; Wu L; Cai D; Hong W; Wu Y; Cao Z; Zheng C; Li W
    Peptides; 2011 Jan; 32(1):11-9. PubMed ID: 20950663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
    Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
    Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus.
    Tanida I; Shirasago Y; Suzuki R; Abe R; Wakita T; Hanada K; Fukasawa M
    Jpn J Infect Dis; 2015; 68(4):268-75. PubMed ID: 25672401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.
    Basu A; Kanda T; Beyene A; Saito K; Meyer K; Ray R
    J Virol; 2007 Apr; 81(8):3933-41. PubMed ID: 17287282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiviral activity of doxycycline against vesicular stomatitis virus in vitro.
    Wu ZC; Wang X; Wei JC; Li BB; Shao DH; Li YM; Liu K; Shi YY; Zhou B; Qiu YF; Ma ZY
    FEMS Microbiol Lett; 2015 Nov; 362(22):. PubMed ID: 26459887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plant-derived antivirals against hepatitis c virus infection.
    Jardim ACG; Shimizu JF; Rahal P; Harris M
    Virol J; 2018 Feb; 15(1):34. PubMed ID: 29439720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus.
    Yamashita M; Iida M; Tada M; Shirasago Y; Fukasawa M; Nagase S; Watari A; Ishii-Watabe A; Yagi K; Kondoh M
    J Pharmacol Exp Ther; 2015 Apr; 353(1):112-8. PubMed ID: 25628391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors.
    Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP
    Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors.
    Yu F; Peng Y; Wang Q; Shi Y; Si L; Wang H; Zheng Y; Lee E; Xiao S; Yu M; Li Y; Zhang C; Tang H; Wang C; Zhang L; Zhou D
    Eur J Med Chem; 2014 Apr; 77():258-68. PubMed ID: 24650713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent.
    Xing Y; Chen R; Li F; Xu B; Han L; Liu C; Tong Y; Jiu Y; Zhong J; Zhou GC
    Virology; 2023 Sep; 586():91-104. PubMed ID: 37506590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.